The use of blockchain technology in the biomedical industry has tripled this year
According to the nonprofit organization of the Pistoia Alliance poll, 60% of professionals in the biomedical industry either already use or are testing blockchain technology, which is almost 3 times more than last year.
A non-profit organization of the Pistoia Alliance has published a report on the results of the study and reported that the use of blockchain technology in the biomedical industry has tripled in comparison with last year.
One of the main barriers remaining 40% of the participants in the industry to introduce innovative technology, lack of personnel:
“In our last survey 55% of respondents said that the largest barrier to implementation of the blockchain is the lack of professionals.”
In our latest survey, 55% of respondents said that the biggest barrier to implementing #the blockchain is a lack of skilled personnel. Want to know what else we found out? https://t.co/1lxy3Robrq
— The Pistoia Alliance (@PistoiaAlliance) September 27, 2018
Also 16% of respondents admitted that they are extremely difficult given the understanding of the blockchain technology.
The advantages of the blockchain technology, according to industry players, is the inability to change transaction (73%) and the transparency of systems of distributed registry (39%). However, 18% of respondents do not see value in the use of technology:
“Almost 1/5 of professionals believe that the use of the blockchain will not bring added value”
As noted, Steve Austin, President of the Pistoia Alliance, founding members of which are such companies as Pfizer, Novartis, GlaxoSmithKline and AstraZeneca, the benefits of blockchain technology to pharmaceutical and biomedical companies, “impossible to ignore”:
“I hope that technology provides the security, reduce the restraint in the exchange of data and information… We believe that the blockchain will open new opportunities in the industry information exchange for the development of new drugs, and ultimately improve the lives of patients”
The survey also showed that in the opinion of professionals biomedical industry, the blockchain technology can be used in the supply chain (30%), in the system of electronic medical records (25%), in the management of clinical trials of new drugs and treatment methods (20%) and research (15%), which has already been proved in practice.
For example, this week it became known that the company BlackBerry has developed a blockchain is a solution for secure storage of patient data, including data exchange with devices of the Internet of things (IoT), and big pharmaceutical conglomerates Pfizer and Genentech announced the creation of a blockchain platform MediLedger aimed to cut off the counterfeit drugs from the supply chain in health facilities.